Shows prognostic relevance of NRF2 levels in high grade serous ovarian cancer, suggesting improved outcomes through biomarker evaluation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hamad et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: